• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I TSH REAGENT KIT; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I TSH REAGENT KIT; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE Back to Search Results
Catalog Number 07P48-30
Medical Device Problem Code Imprecise or Erratic Results (4059)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/02/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 07p48, that has a similar product distributed in the us with the same list number, and a 510k/pma/bla number of k983442.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed discrepant alinity i tsh results generated for an 82-year-old female patient sample.The following data was provided (customers reference range 0.35 uiu/ml to 4.94 uiu/ml): sample id (b)(6): (b)(6) 2026 initial result in lithium heparin plasma tube = 0.14 miu/l, (b)(6) 2026 repeat result = 0.07 miu/l.Same patient: (b)(6) 2026 result in serum gel separator tube = 0.79 miu/l, (b)(6) 2026 repeat result = 0.83 miu/l.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TSH REAGENT KIT
Common Device Name
RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key24894923
Report Number3005094123-2026-00178
Device Sequence Number9036568
Product Code JLW
UDI-Device Identifier00380740131159
UDI-Public(01)00380740131159(17)270527(10)82588UD00
Combination Product (Y/N)N
Initial Reporter CountryBU
PMA/510(K) Number
K983442
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number07P48-30
Device Lot Number82588UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/07/2026
Supplement Date Received by Manufacturer06/15/2026
Initial Report FDA Received Date04/16/2026
Supplement Report FDA Received Date06/15/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/12/2026
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient Age82 YR
Patient SexFemale
-
-